These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 37650687)
1. Pan-cancer analysis: SPAG5 is an immunological and prognostic biomarker for multiple cancers. Gao X; Bu H; Gao X; Wang Y; Wang L; Zhang Z FASEB J; 2023 Oct; 37(10):e23159. PubMed ID: 37650687 [TBL] [Abstract][Full Text] [Related]
2. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study. Chen W; Chen X; Li S; Ren B J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771 [TBL] [Abstract][Full Text] [Related]
3. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer. Li M; Li A; Zhou S; Lv H; Yang W J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840 [TBL] [Abstract][Full Text] [Related]
4. SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas. Xiao G; Xu X; Chen Z; Zeng J; Xie J Clin Med Insights Oncol; 2023; 17():11795549231199915. PubMed ID: 37744424 [TBL] [Abstract][Full Text] [Related]
5. p53 suppression is essential for oncogenic SPAG5 upregulation in lung adenocarcinoma. Wang T; Li K; Song H; Xu D; Liao Y; Jing B; Guo W; Hu M; Kuang Y; Sun B; Ling J; Zhang T; Xu J; Yao F; Deng J Biochem Biophys Res Commun; 2019 May; 513(2):319-325. PubMed ID: 30955859 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of sperm-associated antigen 5 expression in endometrial carcinoma was associated with poor prognosis and immune dysregulation, and promoted cell migration and invasion. Chen M; Wang D; Xu Y; Yang C Sci Rep; 2024 Jun; 14(1):13415. PubMed ID: 38862557 [TBL] [Abstract][Full Text] [Related]
7. Zhang W; Liao Y; Liu C; Liu L; Zhou X Dis Markers; 2023; 2023():6729717. PubMed ID: 36845017 [TBL] [Abstract][Full Text] [Related]
8. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma. Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483 [TBL] [Abstract][Full Text] [Related]
9. Pan-cancer analyses identify MIR210HG overexpression, epigenetic regulation and oncogenic role in human tumors and its interaction with the tumor microenvironment. Yadav G; Kulshreshtha R Life Sci; 2024 Feb; 339():122438. PubMed ID: 38242493 [TBL] [Abstract][Full Text] [Related]
10. Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancer. Canu V; Vaccarella S; Sacconi A; Pulito C; Goeman F; Pallocca M; Rutigliano D; Lev S; Strano S; Blandino G Cell Death Dis; 2024 Aug; 15(8):603. PubMed ID: 39164278 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y Front Immunol; 2023; 14():1155182. PubMed ID: 37275857 [TBL] [Abstract][Full Text] [Related]
12. High expression of sperm-associated antigen 5 correlates with poor survival in ovarian cancer. Zhang M; Sha L; Hou N; Shi C; Tan L Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31985007 [TBL] [Abstract][Full Text] [Related]
13. Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis. Zhou H; Wang SC; Ma JM; Yu LQ; Jing JS Med Sci Monit; 2018 Aug; 24():6021-6028. PubMed ID: 30157168 [TBL] [Abstract][Full Text] [Related]
14. CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers. Qi J; Wu G; He M; Xu Y; Yang Z; Ding L; Wang Y; Zhang Z Aging (Albany NY); 2024 Jan; 16(2):1879-1896. PubMed ID: 38261737 [TBL] [Abstract][Full Text] [Related]
15. SPAG5 and ASPM play important roles in gastric cancer: An observational study. Xue M; Ma C; Shan H; Hou S; Kang C Medicine (Baltimore); 2024 Jun; 103(24):e38499. PubMed ID: 38875410 [TBL] [Abstract][Full Text] [Related]
16. SPAG5 as a novel biomarker and potential therapeutic target via regulating AKT pathway in multiple myeloma. Zeng X; Xu W; Tong J; Liu J; Zhang Z; Liu M; Wu C; Yu Q; Ye C; Wu C; Wu Y; Yan H Leuk Lymphoma; 2022 Nov; 63(11):2565-2572. PubMed ID: 35730922 [TBL] [Abstract][Full Text] [Related]
17. HGH1 and the immune landscape: a novel prognostic marker for immune-desert tumor microenvironment identification and immunotherapy outcome prediction in human cancers. Wu G; Dong Y; Hu Q; Ma H; Xu Q; Xu K; Chen H; Yang Z; He M Cell Cycle; 2023 Sep; 22(18):1969-1985. PubMed ID: 37811868 [TBL] [Abstract][Full Text] [Related]
18. ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis. Lin Y; Zhang Y; Tuo Z; Gao L; Ding D; Bi L; Yu D; Lv Z; Wang J; Chen X BMC Cancer; 2023 Mar; 23(1):285. PubMed ID: 36978046 [TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Analysis of the Prognostic, Immunological and Diagnostic Role of CCNF in Pan-cancer. Gao X; Bu H; Ge J; Gao X; Wang Y; Zhang Z; Wang L J Cancer; 2023; 14(13):2431-2442. PubMed ID: 37670965 [No Abstract] [Full Text] [Related]
20. SPAG5 promotes osteosarcoma metastasis via activation of FOXM1/MMP2 axis. Li Z; Li H; Chen J; Luo H; Zeng J; Yao Y; Duan M Int J Biochem Cell Biol; 2020 Sep; 126():105797. PubMed ID: 32668328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]